GlaxoSmithKline S.A.E (EGX:BIOC)

GlaxoSmithKline S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	5,610	5,316	3,007	2,969	3,187	2,579
Market Cap Growth	70.40%	76.81%	1.27%	-6.84%	23.57%	82.08%
Enterprise Value	5,212	6,238	3,430	2,758	2,079	2,840
Last Close Price	67.17	62.64	35.43	34.08	33.07	25.86
PE Ratio	26.31	24.93	17.28	49.11	4.33	16.68
PS Ratio	1.50	1.43	1.00	1.33	1.75	1.42
PB Ratio	2.53	2.40	1.51	1.51	1.84	1.90
P/TBV Ratio	2.53	2.40	1.51	1.51	2.00	2.31
P/FCF Ratio	88.27	83.64	-	13.18	3.23	16.49
P/OCF Ratio	23.29	22.07	-	9.82	3.08	13.42
EV/Sales Ratio	1.40	1.67	1.15	1.23	1.14	1.57
EV/EBITDA Ratio	16.63	23.53	7.36	5.71	42.79	10.20
EV/EBIT Ratio	20.69	28.79	8.05	6.15	135.68	11.73
EV/FCF Ratio	82.02	98.16	-	12.25	2.11	18.15
Debt / Equity Ratio	0.04	0.04	0.06	0.05	0.04	0.13
Debt / EBITDA Ratio	0.29	0.29	0.25	0.20	1.07	0.60
Debt / FCF Ratio	1.29	1.29	-	0.43	0.07	1.15
Net Debt / Equity Ratio	-0.18	-0.18	0.02	-0.37	-0.30	0.08
Net Debt / EBITDA Ratio	-1.50	-1.50	0.09	-1.52	-10.62	0.38
Net Debt / FCF Ratio	-6.26	-6.26	-0.08	-3.25	-0.52	0.68
Asset Turnover	0.92	0.92	0.83	0.66	0.65	0.80
Inventory Turnover	2.58	2.58	2.51	2.46	2.57	2.31
Quick Ratio	0.57	0.57	0.59	1.01	0.95	0.73
Current Ratio	1.62	1.62	1.82	1.88	1.76	1.53
Return on Equity (ROE)	10.12%	10.12%	8.79%	3.27%	-7.38%	12.03%
Return on Assets (ROA)	3.32%	3.32%	7.38%	8.32%	0.34%	6.66%
Return on Invested Capital (ROIC)	5.94%	7.36%	13.37%	18.54%	1.15%	14.91%
Return on Capital Employed (ROCE)	9.50%	9.50%	20.50%	22.10%	0.90%	17.10%
Earnings Yield	3.80%	4.01%	5.79%	2.04%	23.08%	6.00%
FCF Yield	1.13%	1.20%	-17.58%	7.58%	30.98%	6.07%
Dividend Yield	1.49%	1.60%	-	2.20%	-	2.90%
Payout Ratio	6.63%	6.63%	40.05%	217.67%	15.10%	3.61%
Total Shareholder Return	1.47%	1.60%	-	2.20%	-	2.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.